Hasnain Faheem

Director at IMMUNIC, INC. · on record since Aug 15, 2016
Director at TERCICA INC · on record since Feb 28, 2008
EVP, Oncology/Rheumatology SBU at BIOGEN INC. · on record since Feb 14, 2008
Director at PDL BIOPHARMA, INC. · on record since Oct 3, 2008
President & CEO at PDL BIOPHARMA, INC. · on record since Oct 3, 2008
Director at Pernix Sleep, Inc. · on record since Sep 21, 2010
Director at AMBIT BIOSCIENCES CORP · on record since May 21, 2013
Director at Receptos, Inc. · on record since May 14, 2013
Director at Kura Oncology, Inc. · on record since Jun 4, 2026
President & CEO at Receptos, Inc. · on record since Nov 12, 2014
Director at Forte Biosciences, Inc. · on record since Apr 21, 2017
Director at Gossamer Bio, Inc. · on record since Mar 26, 2019
Director at Mirati Therapeutics, Inc. · on record since Feb 20, 2019
Director at Nuvation Bio Inc. · on record since Jun 30, 2020
President & CEO at Gossamer Bio, Inc. · on record since Mar 26, 2019
Director at ABBOTT BIOTHERAPEUTICS CORP · on record since Dec 19, 2008
President & CEO at ABBOTT BIOTHERAPEUTICS CORP · on record since Dec 19, 2008

Insider trading activity of Hasnain Faheem

Transactions on record: 205; since Feb 8, 2006

Open-market buys: 14; $5.9M

Open-market sells: 42; $26.4M

Companies traded: 13; last filing Aug 26, 2026

Figures computed from official regulatory filings — .

Companies where Hasnain Faheem has traded

50 tx · $4.8M · Aug 26, 2026
16 tx · $465.8K · Jun 4, 2026
17 tx · $870K · Jan 23, 2024
3 tx · $300K · Feb 26, 2021
9 tx · $2.2M · Oct 4, 2019
8 tx · $1M · Sep 17, 2018
12 tx · $102.8M · Aug 27, 2015
9 tx · $1.7M · Nov 12, 2014
8 tx · Mar 8, 2013
9 tx · $13.8M · Apr 23, 2010
2 tx · $152.3K · Oct 20, 2008
2 tx · Oct 3, 2008
60 tx · $6.3M · Jul 10, 2008

Track record of Hasnain Faheem

Statistical track record

Free account

Open-market buys: 14

Last buy: Jun 21, 2024

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of Hasnain Faheem

Co-insiders of Hasnain Faheem

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
Gossamer Bio, Inc.Listing on record	Aug 26, 2026	AwardD (derivative)	166	1,000.00 USD	$166K	SEC
Gossamer Bio, Inc.Listing on record	Aug 26, 2026	AwardD (derivative)	5,800,051	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Kura Oncology, Inc.Listing on record	Jun 4, 2026	AwardD (derivative)	35,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Gossamer Bio, Inc.Listing on record	Mar 20, 2026	AwardD (derivative)	1,540,000	—	n/a (No price was disclosed in the filing)	SEC
Gossamer Bio, Inc.Listing on record	Mar 20, 2026	AwardD (derivative)	650,000	—	n/a (No price was disclosed in the filing)	SEC
Gossamer Bio, Inc.Listing on record	Mar 20, 2026	OtherD (derivative)	-43,500	—	n/a (No price was disclosed in the filing)	SEC
Gossamer Bio, Inc.Listing on record	Mar 20, 2026	AwardD (derivative)	1,680,000	—	n/a (No price was disclosed in the filing)	SEC
Gossamer Bio, Inc.Listing on record	Mar 20, 2026	OtherD (derivative)	-1,680,000	—	n/a (No price was disclosed in the filing)	SEC
Gossamer Bio, Inc.Listing on record	Mar 20, 2026	AwardD (derivative)	325,000	—	n/a (No price was disclosed in the filing)	SEC
Gossamer Bio, Inc.Listing on record	Mar 20, 2026	OtherD (derivative)	-650,000	—	n/a (No price was disclosed in the filing)	SEC
Gossamer Bio, Inc.Listing on record	Mar 20, 2026	AwardD (derivative)	544,500	—	n/a (No price was disclosed in the filing)	SEC
Gossamer Bio, Inc.Listing on record	Mar 20, 2026	AwardD (derivative)	1,312,500	—	n/a (No price was disclosed in the filing)	SEC
Gossamer Bio, Inc.Listing on record	Mar 20, 2026	OtherD (derivative)	-47,000	—	n/a (No price was disclosed in the filing)	SEC
Gossamer Bio, Inc.Listing on record	Mar 20, 2026	OtherD (derivative)	-544,500	—	n/a (No price was disclosed in the filing)	SEC
Gossamer Bio, Inc.Listing on record	Mar 20, 2026	AwardD (derivative)	47,000	—	n/a (No price was disclosed in the filing)	SEC
Gossamer Bio, Inc.Listing on record	Mar 20, 2026	AwardD (derivative)	544,500	—	n/a (No price was disclosed in the filing)	SEC
Gossamer Bio, Inc.Listing on record	Mar 20, 2026	OtherD (derivative)	-544,500	—	n/a (No price was disclosed in the filing)	SEC
Gossamer Bio, Inc.Listing on record	Mar 20, 2026	OtherD (derivative)	-1,540,000	—	n/a (No price was disclosed in the filing)	SEC
Gossamer Bio, Inc.Listing on record	Mar 20, 2026	OtherD (derivative)	-437,500	—	n/a (No price was disclosed in the filing)	SEC
Gossamer Bio, Inc.Listing on record	Mar 20, 2026	AwardD (derivative)	43,500	—	n/a (No price was disclosed in the filing)	SEC
Gossamer Bio, Inc.Listing on record	Mar 20, 2026	AwardD (derivative)	437,500	—	n/a (No price was disclosed in the filing)	SEC
Gossamer Bio, Inc.Listing on record	Mar 20, 2026	OtherD (derivative)	-325,000	—	n/a (No price was disclosed in the filing)	SEC
Gossamer Bio, Inc.Listing on record	Mar 20, 2026	OtherD (derivative)	-1,312,500	—	n/a (No price was disclosed in the filing)	SEC
Gossamer Bio, Inc.Listing on record	Jan 5, 2026	Award	280,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Gossamer Bio, Inc.Listing on record	Jan 5, 2026	AwardD (derivative)	1,680,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Gossamer Bio, Inc.Listing on record	Aug 26, 2026	AwardD (derivative)	166	1,000.00 USD	$166K	SEC
Gossamer Bio, Inc.Listing on record	Aug 26, 2026	AwardD (derivative)	5,800,051	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Kura Oncology, Inc.Listing on record	Jun 4, 2026	AwardD (derivative)	35,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Gossamer Bio, Inc.Listing on record	Mar 20, 2026	AwardD (derivative)	1,540,000	—	n/a (No price was disclosed in the filing)	SEC
Gossamer Bio, Inc.Listing on record	Mar 20, 2026	AwardD (derivative)	650,000	—	n/a (No price was disclosed in the filing)	SEC
Gossamer Bio, Inc.Listing on record	Mar 20, 2026	OtherD (derivative)	-43,500	—	n/a (No price was disclosed in the filing)	SEC
Gossamer Bio, Inc.Listing on record	Mar 20, 2026	AwardD (derivative)	1,680,000	—	n/a (No price was disclosed in the filing)	SEC
Gossamer Bio, Inc.Listing on record	Mar 20, 2026	OtherD (derivative)	-1,680,000	—	n/a (No price was disclosed in the filing)	SEC
Gossamer Bio, Inc.Listing on record	Mar 20, 2026	AwardD (derivative)	325,000	—	n/a (No price was disclosed in the filing)	SEC
Gossamer Bio, Inc.Listing on record	Mar 20, 2026	OtherD (derivative)	-650,000	—	n/a (No price was disclosed in the filing)	SEC
Gossamer Bio, Inc.Listing on record	Mar 20, 2026	AwardD (derivative)	544,500	—	n/a (No price was disclosed in the filing)	SEC
Gossamer Bio, Inc.Listing on record	Mar 20, 2026	AwardD (derivative)	1,312,500	—	n/a (No price was disclosed in the filing)	SEC
Gossamer Bio, Inc.Listing on record	Mar 20, 2026	OtherD (derivative)	-47,000	—	n/a (No price was disclosed in the filing)	SEC
Gossamer Bio, Inc.Listing on record	Mar 20, 2026	OtherD (derivative)	-544,500	—	n/a (No price was disclosed in the filing)	SEC
Gossamer Bio, Inc.Listing on record	Mar 20, 2026	AwardD (derivative)	47,000	—	n/a (No price was disclosed in the filing)	SEC
Gossamer Bio, Inc.Listing on record	Mar 20, 2026	AwardD (derivative)	544,500	—	n/a (No price was disclosed in the filing)	SEC
Gossamer Bio, Inc.Listing on record	Mar 20, 2026	OtherD (derivative)	-544,500	—	n/a (No price was disclosed in the filing)	SEC
Gossamer Bio, Inc.Listing on record	Mar 20, 2026	OtherD (derivative)	-1,540,000	—	n/a (No price was disclosed in the filing)	SEC
Gossamer Bio, Inc.Listing on record	Mar 20, 2026	OtherD (derivative)	-437,500	—	n/a (No price was disclosed in the filing)	SEC
Gossamer Bio, Inc.Listing on record	Mar 20, 2026	AwardD (derivative)	43,500	—	n/a (No price was disclosed in the filing)	SEC
Gossamer Bio, Inc.Listing on record	Mar 20, 2026	AwardD (derivative)	437,500	—	n/a (No price was disclosed in the filing)	SEC
Gossamer Bio, Inc.Listing on record	Mar 20, 2026	OtherD (derivative)	-325,000	—	n/a (No price was disclosed in the filing)	SEC
Gossamer Bio, Inc.Listing on record	Mar 20, 2026	OtherD (derivative)	-1,312,500	—	n/a (No price was disclosed in the filing)	SEC
Gossamer Bio, Inc.Listing on record	Jan 5, 2026	Award	280,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Gossamer Bio, Inc.Listing on record	Jan 5, 2026	AwardD (derivative)	1,680,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC